Qian Dong
Has grant
Teaching assistant for genetics lab
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Qian Dong is a Teaching Assistant for the Genetics Lab at Western Kentucky University, USA. Their research focuses on neural stem cell biology, with recent articles exploring topics such as dedifferentiation-derived neural stem cells and the role of glial Hedgehog signaling in neural stem cell proliferation in Drosophila. This work contributes to a deeper understanding of cellular processes and their implications in genetics.
Recent Grants
Grant: Close
Mechanisms regulating Drosophila neural stem cell proliferation
Open Date: 2017-07-01
Close Date: 2021-05-01
Grant: Close
Functional Characterization of a Cathepsin L in Drosophila Melanogaster
Open Date: 2013-08-01
Close Date: 2015-07-01
Articles (5)
Tumors adapt their metabolism to sustain increased proliferation, rendering them particularly vulnerable to fluctuations in nutrient availability. However, the role of the tumor microenvironment in modulating sensitivity to nutrient restriction (NR) remains poorly understood. Using a Drosophila brain dedifferentiation neural stem cell (NSC) tumor model induced by Prospero (Pros) inhibition, we show that tumor sensitivity to NR is governed by the blood–brain barrier (BBB) glia. We found that the SLC36 amino acid transporter Pathetic (Path) regulates brain branched-chain amino acids (BCAAs) levels. Under NR, while wild-type buffers against low nutrient levels by upregulating Path, tumor glia down-regulate Path. Furthermore, Path is specifically required by the tumor (but not wildtype) BBB; its downregulation causes reduced cell cycle progression of BBB glial cells and, in turn, restricts NSC tumor growth. Path influences BBB glial cell cycle via the BCAA-mTor-S6K pathway, and its expression is controlled by Ilp6 levels and the Insulin/PI3K pathway. Overexpression of Path is sufficient to counteract the inhibitory effects of NR on tumor growth. These findings suggest that Path levels at the glial niche BBB play a key role in determining tumor sensitivity to NR.
Year:
2025
Year:
2025
Tumours adapt their metabolism to sustain increased proliferation, rendering them particularly vulnerable to fluctuations in nutrient availability. However, the role of the tumour microenvironment in modulating sensitivity to nutrient restriction (NR) remains poorly understood. Using a Drosophila brain dedifferentiation neural stem cell (NSC) tumour model induced by Prospero (Pros) inhibition, we show that tumour sensitivity to NR is governed by the perineural glial (PG) cells of the blood-brain barrier (BBB), a major component of the glial niche surrounding the tumour. We identify the SLC36 amino acid transporter Pathetic (Path) as a crucial regulator of nutrient sensitivity. Under NR, while wildtype buffers against low nutrient levels by upregulating Path, tumour glia downregulate Path. Furthermore, Path is specifically required by the tumour (but not wildtype) PG; its downregulation causes reduced proliferation of PG cells and, in turn, restricts NSC tumour growth. Path influences PG proliferation via the mTor-S6K pathway, and its expression is controlled by Ilp6 levels and the Insulin/PI3K pathway. Overexpression of Path is sufficient to counteract the inhibitory effects of NR on tumour growth. These findings suggest that Path levels at the BBB play a key role in determining tumour sensitivity to NR.
Year:
2025
Year:
2023
Year:
2021
Collaborators (3)
Fumiaki Obata
Team Leader
Kyoto University
Louise Cheng
Professor
University of Melbourne
Kieran Harvey
Group Leader
Peter MacCallum Cancer Institute
Make your next move.
Prepare your application
Review drafts before you send them.